Vaccine Development Current Events | Vaccine Development News | 4
|
| Page
4 of
35 |
692 Results |
|
|
|
Sort By:
Page Views | Date |
UCSB researchers develop cross-protective vaccine
Doctors have always hoped that scientists might one day create a vaccination that would treat a broad spectrum of maladies. They could only imagine that there might be one vaccine that would protect against, say, 2,500 strains of Salmonella. view more (2008-10-22)
New rabies vaccine may require only a single shot... not 6
A person, usually a child, dies of rabies every 20 minutes. However, only one inoculation may be all it takes for rabies vaccination, according to new research published in the Journal of Infectious Diseases by researchers at the Jefferson Vaccine Center. view more (2009-09-21)
Smokers invite to test vaccine against nicotine addiction
UCSF's Habit Abatement Clinic is testing a vaccine that enlists help from the immune system to keep nicotine away from the brain. The vaccine is designed to help smokers quit and to limit the urge to start smoking again. view more (2006-06-12)
Clinical trial evaluating brain cancer vaccine is underway at NYU
A clinical trial evaluating a brain cancer vaccine in patients with newly diagnosed brain cancer has begun at NYU Medical Center. view more (2007-10-22)
College students who feel 'invincible' unlikely to accept vaccines, MU researcher finds
Vaccines to protect against sexually transmitted diseases, including HIV and herpes, are being developed and may soon be available to college students. view more (2009-07-30)
Cellular antacids give vaccines a boost
Scientists in Italy have found that a drug that blocks acid buildup inside cells revs up the immune response to vaccines. view more (2005-09-12)
First European trial for new breast cancer vaccine
European clinical trials are under way in Denmark and the UK testing a new breast cancer vaccine targeted against the HER-2 growth factor.* HER-2 is overexpressed in about a quarter of all breast cancers and has become a key target for new treatments, such as the monoclonal antibody therapy Herceptin. But, the development of a vaccine by Danish... view more... (2002-03-18)
SSX, a new family of cancer vaccine targets
Scientists from the Cancer Vaccine Collaborative (CVC) have discovered that the cancer-specific protein, SSX-2, induces a spontaneous immunological reaction against cancer cells in melanoma patients, offering a new target for the development of a therapeutic melanoma vaccine. SSX-2 is the prototype of the SSX family, and is part of a larger group... view more... (2004-04-01)
Number of cases of most vaccine-preventable diseases in US at all-time low
A comparison of illness and death rates for 13 vaccine-preventable diseases in the U.S., before and after use of the vaccine, indicates there have been significant decreases in the number of cases, hospitalizations and deaths for each of the diseases examined. view more (2007-11-14)
Response from Dr Peter Sasieni, senior scientist at Imperial Cancer Research Fund, in response to new research* that shows HPV is present in 99.7% of cervical cancers.
Response from Dr Peter Sasieni, senior scientist at Imperial Cancer Research Fund, in response to new research* that shows HPV is present in 99.7% of cervical cancers. view more (1999-08-25)
Study shows continued success for new HPV vaccine against virus responsible for cervical cancer
A new vaccine aimed at preventing cervical cancer is nearly 100 percent effective against the two types of the human papillomavirus (HPV) responsible for most cases of cervical cancer. view more (2007-05-10)
More than half of Texas physicians do not always recommend HPV vaccine to girls
The Advisory Committee on Immunization Practices recommends the human papillomavirus vaccination for all 11- and 12-year-old girls, but results of a recent survey showed that more than half of Texas physicians do not follow these recommendations. view more (2009-08-06)
"EuroVacc 02" HIV Vaccine trial begins
The European Vaccine Effort against HIV/AIDS, today announced that a phase I clinical trial of novel investigational vaccines comprising DNA-HIV-C and NYVAC-HIV-C for the prevention of HIV infection has started in Lausanne and London in February 2005. These vaccines are based on HIV subtype C, which is prevalent in China, India and sub-Saharan... view more... (2005-02-16)
Novel tuberculosis vaccine in Germany in clinical phase
For the first time in more than 80 years a promising live vaccine against tuberculosis has passed into the clinical phase in Germany: Since Monday of this week the new vaccine, which goes by the designation "VPM1002", has begun safety testing on volunteers in a Phase I clinical trial in Neuss, Germany. view more (2008-09-12)
Encouraging Results For Long-Term Efficacy Of Meningitis C Vaccine
Four-year results assessing the efficacy of the UK meningitis C vaccine programme are reported in a research letter in this week's issue of THE LANCET. The vaccine is now showing long-term efficacy, except for infants initially vaccinated younger than 5 months of age. The meningococcal serogroup C conjugate (MCC) vaccine programme was introduced... view more... (2004-07-21)
1 in 4 California adolescent girls has had HPV vaccine
Less than two years after the HPV vaccine was approved as a routine vaccination for girls aged 11 and older, one-quarter of California adolescent girls have started the series of shots that protect against human papillomavirus, which is strongly linked to cervical cancer. view more (2009-02-18)
India continues to progress in AIDS vaccine development efforts
A second Phase I AIDS vaccine clinical trial in India was successfully completed, the Indian Council of Medical Research, the National AIDS Control Organization and the International AIDS Vaccine Initiative announced. The results of the trial of an MVA-based AIDS vaccine candidate (TBC-M4), which was conducted in Chennai, indicated that the... view more... (2008-08-18)
Early promising results in malaria vaccine trial in Mali
A small clinical trial conducted by an international team of researchers in Mali has found that a candidate malaria vaccine was safe and elicited strong immune responses in the 40 Malian adults who received it. view more (2008-01-23)
Flu vaccine appears safe for young children
Use of the influenza vaccine in children 6 to 23 months is not associated with an increased risk for a medical visit for any serious conditions. view more (2006-10-25)
Cancer Patients not getting live-saving flu and pneumonia shots
Although flu and pneumonia can be lethal for cancer patients, more than one quarter of patients undergoing radiation therapy are not complying with national guidelines to be vaccinated against these potentially life-threatening yet preventable illnesses. view more (2007-10-29)
|
|
| Page
4 of
35 |
692 Results |
|
|
|
Sort By:
Page Views | Date |
|
